Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic influence on factor VIII pharmacokinetics in severe hemophilia A
2012-001669-34Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of octocog alfa and recombinant human coagulation factor VIII in hemophilia A, sponsored by Medical University of Vienna. Primary endpoints: Factor VIII pharmacokinetics and clearance and Age influence on factor VIII pharmacokinetics. Started Jun 2012; status: completed.
02
Drugs
octocog alfarecombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2012-001669-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001669-34.